Gene therapy provides safe, long-term relief for patients with severe hemophilia B
Gene therapy pioneered by St. Jude Children’s Research Hospital, University College London and the Royal Free Hospital provides provided men with hemophilia B reliable relief from the bleeding disorder, paving the way for more active lifestyles
Source: St. Jude Children's Research Hospital - Category: Pediatrics Source Type: news
More News: Bleeding | Children | Gene Therapy | Genetics | Haemophilia | Hemophilia | Hospitals | Pediatrics